 | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | | | | Abortion providers including Planned Parenthood on Thursday sued to block a sweeping new Kentucky law that forces them to stop offering the procedure until they can meet certain requirements, saying it amounted to an unconstitutional ban on abortions. | | | | | | This spring, the U.S. Supreme Court is expected to roll back constitutional protections for abortion that have been in place since the 1973 Roe v. Wade landmark ruling. | | | | | | Florida Governor Ron DeSantis on Thursday signed into law a ban on abortions after 15 weeks of pregnancy, a restriction the U.S. Supreme Court could soon declare to be constitutional when it finishes reviewing a similar Mississippi ban this spring. | | | | | | Italy reported 64,951 COVID-19 related cases on Thursday, against 62,037 the day before, the health ministry said, while the number of deaths fell to 149 from 155. | | | | | | Canada on Thursday authorized British drugmaker AstraZeneca Plc's antibody-based therapy for preventing COVID-19 infections, giving itself another weapon against the disease as cases rise in the country. | | | | | | Africa is experiencing its longest-running decline in weekly COVID-19 infections since the start of the pandemic, the World Health Organization said on Thursday. | | | | | | Britain's medicines regulator on Thursday approved the use of Moderna's COVID-19 vaccine in children between six and 11 years, as the country bolsters itself for fighting coronavirus infections amid the spread of new virus variants. | | | | | | England's COVID-19 prevalence fell to 1 in 14 people in the week ending April 9, Britain's Office for National Statistics said on Thursday, compared with a record high of 1 in 13 recorded in the previous two weeks. | | | | | | The U.S. Food and Drug Administration has extended by three months its review of Regeneron Pharmaceuticals Inc's application for the full approval of its COVID-19 antibody therapy, the U.S. drugmaker said on Thursday. | | | | | |
